Chubachi Shotaro, Takahashi Saeko, Tsutsumi Akihiro, Kameyama Naofumi, Sasaki Mamoru, Naoki Katsuhiko, Soejima Kenzo, Nakamura Hidetoshi, Asano Koichiro, Betsuyaku Tomoko
Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo.
Department of Respiratory Medicine, Saitama Medical University, Irima-gun, Saitama.
Int J Chron Obstruct Pulmon Dis. 2017 May 30;12:1613-1624. doi: 10.2147/COPD.S132709. eCollection 2017.
Only a few studies have evaluated the radiologic features of pre-existing structural abnormalities where lung cancer may develop. This study aimed to analyze the computed tomography (CT) images of lung areas where new cancer developed in chronic obstructive pulmonary disease (COPD) patients.
We conducted a multicenter, longitudinal cohort study, called the Keio COPD Comorbidity Research, to assess the incidence of lung cancer. Emphysema and interstitial abnormalities were evaluated in 240 COPD patients who had baseline CT scans applicable for further digital analyses. For patients who developed lung cancer during the 3-year follow-up period, the local spherical lung density of the precancerous area was individually quantified.
Lung cancer was newly diagnosed in 21 participants (2.3% per year). The percent-age of low attenuation area in patients who developed lung cancer was higher than that of the other patients (20.0% vs 10.4%, =0.014). The presence of emphysema (odds ratio [OR] 4.2, 95% confidence interval [CI] 1.0-29.0, =0.049) or interstitial lung abnormalities (OR 15.6, 95% CI 4.4-65.4, <0.0001) independently increased the risk for lung cancer. Compared with the density of the entire lung, the local density of the precancerous area was almost the same in patients with heterogeneous emphysema, but it was higher in most patients with interstitial abnormalities.
The presence of emphysema or interstitial abnormalities or a combination of both were independent predictors of lung cancer development in COPD patients. Furthermore, lung cancer most often developed in non-emphysematous areas or in interstitial abnormalities.
仅有少数研究评估了肺癌可能发生部位的既往结构异常的放射学特征。本研究旨在分析慢性阻塞性肺疾病(COPD)患者新发癌症部位的计算机断层扫描(CT)图像。
我们开展了一项名为庆应义塾大学慢性阻塞性肺疾病合并症研究的多中心纵向队列研究,以评估肺癌的发病率。对240例有适用于进一步数字分析的基线CT扫描的慢性阻塞性肺疾病患者的肺气肿和间质异常情况进行了评估。对于在3年随访期内发生肺癌的患者,对癌前区域的局部球形肺密度进行了个体量化。
21名参与者新诊断为肺癌(每年2.3%)。发生肺癌患者的低衰减区域百分比高于其他患者(20.0%对10.4%,P=0.014)。肺气肿(优势比[OR]4.2,95%置信区间[CI]1.0 - 29.0,P=0.049)或间质性肺异常(OR 15.6,95%CI 4.4 - 65.4,P<0.0001)独立增加肺癌风险。与全肺密度相比,异质性肺气肿患者癌前区域的局部密度几乎相同,但大多数间质性异常患者的局部密度更高。
肺气肿或间质性异常或两者并存是慢性阻塞性肺疾病患者发生肺癌的独立预测因素。此外,肺癌最常发生在非肺气肿区域或间质性异常区域。